[CME myelodysplasia - a frequent hematologic neoplasia in the elderly].
Hirslanden Klinik Im Park, Zürich; AndreasKlinik, Cham; Labor Viollier, Basel.
Boris Eugen
BE
Schleiffenbaum
D000369:Aged, 80 and over; D000741:Anemia, Aplastic / Q000145:classification / Q000175:diagnosis / Q000473:pathology; D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001856:Bone Marrow Examination; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D000077209:Decitabine; D003937:Diagnosis, Differential; D018450:Disease Progression; D006410:Hematopoiesis / Q000502:physiology; D006801:Humans; D000077269:Lenalidomide; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000473:pathology; D008297:Male; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011379:Prognosis; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
D013792:Thalidomide; D000077209:Decitabine; D000077269:Lenalidomide; D001374:Azacitidine